Cyclacel Pharmaceuticals, INC. (BGMSP) — S-1/A Filings

All S-1/A filings from Cyclacel Pharmaceuticals, INC.. Browse 4 S-1/A reports with AI-powered summaries and risk analysis.

S-1/A Filings (4)

Cyclacel Amends S-1 for Continuous Offering, Shifts HQ to Malaysia — Jul 31, 2025 Risk: high
Cyclacel Pharmaceuticals, Inc. filed an S-1/A on July 30, 2025, for a delayed or continuous offering of securities under Rule 415, indicating a strategic move t
Cyclacel Pharmaceuticals Files Amendment to S-1 Registration Statement — Apr 25, 2024 Risk: low
Cyclacel Pharmaceuticals, Inc. (BGMSP) filed a Amended IPO Registration (S-1/A) with the SEC on April 25, 2024. Cyclacel Pharmaceuticals, Inc. filed an amendmen
Cyclacel Pharmaceuticals Files Amendment to S-1 Registration Statement — Apr 19, 2024 Risk: low
Cyclacel Pharmaceuticals, Inc. (BGMSP) filed a Amended IPO Registration (S-1/A) with the SEC on April 19, 2024. Cyclacel Pharmaceuticals, Inc. filed an amendmen
Cyclacel Pharmaceuticals Files S-1/A Amendment — Feb 8, 2024 Risk: low
Cyclacel Pharmaceuticals, Inc. (BGMSP) filed a Amended IPO Registration (S-1/A) with the SEC on February 8, 2024. Cyclacel Pharmaceuticals, Inc. filed an S-1/A

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX